Lack of correlation between the promastigote back-transformation assay and miltefosine treatment outcome.
about
Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum.Susceptibility to Miltefosine in Brazilian Clinical Isolates of Leishmania (Viannia) braziliensis.Chemotherapy of leishmaniasis: present challenges.Evaluating drug resistance in visceral leishmaniasis: the challenges.In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series.
P2860
Lack of correlation between the promastigote back-transformation assay and miltefosine treatment outcome.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Lack of correlation between th ...... miltefosine treatment outcome.
@en
Lack of correlation between th ...... miltefosine treatment outcome.
@nl
type
label
Lack of correlation between th ...... miltefosine treatment outcome.
@en
Lack of correlation between th ...... miltefosine treatment outcome.
@nl
prefLabel
Lack of correlation between th ...... miltefosine treatment outcome.
@en
Lack of correlation between th ...... miltefosine treatment outcome.
@nl
P2093
P2860
P356
P1476
Lack of correlation between th ...... miltefosine treatment outcome.
@en
P2093
A Mondelaers
E Eberhardt
J C Dujardin
N R Bhattarai
P Delputte
S Hendrickx
P2860
P304
P356
10.1093/JAC/DKV237
P407
P577
2015-08-07T00:00:00Z